We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.88B
AUM Growth
+$174M
Cap. Flow
+$53.5M
Cap. Flow %
1.38%
Top 10 Hldgs %
24.25%
Holding
1,062
New
39
Increased
382
Reduced
217
Closed
57

Top Buys

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$22.4M
2
CNC icon
Centene
CNC
+$12.9M
3
PHM icon
Pultegroup
PHM
+$9.65M
4
DAL icon
Delta Air Lines
DAL
+$8.76M
5
CI icon
Cigna
CI
+$8.53M

Top Sells

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$24.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$13.4M
3
ADBE icon
Adobe
ADBE
+$11.6M
4
LUV icon
Southwest Airlines
LUV
+$9.91M
5
INTC icon
Intel
INTC
+$8.54M

Sector Composition

Rank Sector Weight
1 Technology 17.13%
2 Financials 15.71%
3 Healthcare 13.47%
4 Consumer Discretionary 13.31%
5 Industrials 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSB
976
DELISTED
Franklin Financial Network, Inc.
FSB
$45K ﹤0.01%
+1,210
New +$42.8K
TECK icon
977
Teck Resources
TECK
$29.6B
$42K ﹤0.01%
1,652
– –
DNTH icon
978
Dianthus Therapeutics
DNTH
$5.84B
$41K ﹤0.01%
+190
New +$42.9K
OBSV
979
DELISTED
ObsEva SA Ordinary Shares
OBSV
$40K ﹤0.01%
+2,618
New +$34.8K
AEM icon
980
Agnico Eagle Mines
AEM
$73.6B
$39K ﹤0.01%
858
– –
CRR
981
DELISTED
Carbo Ceramics Inc.
CRR
$39K ﹤0.01%
+4,216
New +$37.8K
AGIO icon
982
Agios Pharmaceuticals
AGIO
$1.79B
$37K ﹤0.01%
440
+396
+900% +$34.5K
TI
983
DELISTED
Telecom Italia
TI
$37K ﹤0.01%
5,096
– –
LBTYA icon
984
Liberty Global Class A
LBTYA
$3.62B
$34K ﹤0.01%
1,232
– –
LBTYK icon
985
Liberty Global Class C
LBTYK
$3.53B
$33K ﹤0.01%
1,254
– –
IMDZ
986
DELISTED
Immune Design Corp.
IMDZ
$32K ﹤0.01%
+6,930
New +$27.6K
JAZZ icon
987
Jazz Pharmaceuticals
JAZZ
$15.9B
$30K ﹤0.01%
+176
New +$28.8K
JHX icon
988
James Hardie Industries
JHX
$15.3B
$30K ﹤0.01%
1,792
– –
OVV icon
989
Ovintiv
OVV
$17.3B
$28K ﹤0.01%
428
– –
WVE icon
990
Wave Life Sciences
WVE
$1.09B
$27K ﹤0.01%
+714
New +$30.7K
SCG
991
DELISTED
Scana
SCG
$26K ﹤0.01%
682
+594
+675% +$21.6K
AIMT
992
DELISTED
Aimmune Therapeutics
AIMT
$25K ﹤0.01%
+946
New +$29K
CSTE icon
993
Caesarstone
CSTE
$72.3M
$22K ﹤0.01%
1,484
– –
TRQ
994
DELISTED
Turquoise Hill Resources Ltd
TRQ
$21K ﹤0.01%
728
– –
CPF icon
995
Central Pacific Financial
CPF
$1.02B
$19K ﹤0.01%
+660
New +$19.5K
TBHC
996
DELISTED
The Brand House Collective
TBHC
$17K ﹤0.01%
+1,462
New +$16.3K
STN icon
997
Stantec
STN
$8.04B
$17K ﹤0.01%
682
-704
-51% -$17.8K
VRN
998
DELISTED
Veren
VRN
$17K ﹤0.01%
2,324
– –
NGD
999
DELISTED
New Gold Inc
NGD
$16K ﹤0.01%
7,854
– –
VCIT icon
1000
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$9K ﹤0.01%
112
– –
38 39
40
41 42

Similar funds

GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return

Elkfork Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Elkfork Partners held 1,062 positions worth $3.88B, up 4.7% from $3.71B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Elkfork Partners's Q2 2018 filing shows 39 new, 382 increased, 217 reduced and 57 closed positions. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 495,880 shares worth $20.9M. The largest sale was Marriott International, an estimated $24.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Elkfork Partners's largest Q2 2018 buy was Vanguard FTSE Emerging Markets ETF: 495,880 shares worth $20.9M.
  • Elkfork Partners added most to Centene in Q2 2018, an estimated $12.9M increase.
  • Elkfork Partners's biggest Q2 2018 reduction was Marriott International, cutting an estimated $24.1M.
  • Elkfork Partners fully exited Murphy USA in Q2 2018, selling an estimated $3.76M.
  • Elkfork Partners's ten largest holdings make up 24% of its $3.88B portfolio in Q2 2018.
  • Elkfork Partners opened 39 new positions and closed 57 in Q2 2018.
  • Elkfork Partners's portfolio value rose 4.7% quarter-over-quarter to $3.88B.

Based on Elkfork Partners's 13F filing for Q2 2018, filed 14 Aug 2018.